Sera Prognostics, Inc. All rights reserved. PreTRM, Sera Prognostics and their logos are trademarks or registered trademarks of Sera Prognostics, Inc. in the United States. Sera Prognostics Update

Collaboration with Elevance based on health economic analysis from HealthCore Multicenter prospective randomized controlled study within Elevance network Up to 6,500 participants in approx. 15 U.S. sites Evaluates benefit of PreTRM identification of higher risk pregnancies coupled with proactive interventions Primary outcomes are hospital length of stay and neonatal morbidity / mortality Builds data that can be a template for future clinical use of PreTRM PRIME Study: Prematurity Risk Assessment Combined with Clinical Interventions for Improved Neonatal OutcoMEs Elevance Health (formerly Anthem) and Sera Collaborate to Improve Maternal and Neonatal Health